EVIO’s (OTCQB: EVIO) Canadian subsidiary, EVIO Canada, recently finalized a 50% acquisition of Keystone Labs, Inc., a Health Canada-licensed medical cannabis testing facility. An article discussing the company reads: “EVIO Inc. (OTCQB: EVIO) reached a significant milestone in its expansion plans in early May when its new subsidiary, EVIO Canada, announced its acquisition of a 50 percent stake in Keystone Labs, Inc., a licensed Canadian testing laboratory specializing in quality testing for regulated industries such as cannabis. In a May 3, 2018, news release announcing the deal (http://ibn.fm/U6rN2), William Waldrop, CEO and co-founder of EVIO, said Keystone Labs fits perfectly within the company’s expansion plans.”
To view the full article, visit http://ibn.fm/LnZtO
About EVIO, Inc.
EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company’s EVIO Labs division operates coast-to-coast, providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. EVIO is on track to have 18 of its state-of-the-art testing facilities by year-end 2018. For more information, visit the company’s website at www.EvioLabs.com.
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.